NasdaqGS:ALNYBiotechs
Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase
Alnylam Pharmaceuticals (NasdaqGS:ALNY) recently announced the appointment of Dr. Pushkal Garg as Executive Vice President and Chief Research and Development Officer to accelerate its R&D efforts. This leadership change, along with the European Commission's approval of AMVUTTRA for treating transthyretin amyloidosis with cardiomyopathy, contributed to a 23% price rise over the last quarter. While the market has risen 10% over the past year, Alnylam's focus on executive roles and drug...